Table 3.
Primary outcomes | ||||||
---|---|---|---|---|---|---|
Univariable model | Multivariable model* corrected for the influence of both centers |
|||||
Potential predictors of outcome/confounders (as identified in Table 1 and as established in the literature) |
OR | 95% CI | p value | OR | 95% CI | p value |
Return to premorbid neurologic function | ||||||
Female sex | 0.78 | 0.59–1.04 | 0.089 | 0.75 | 0.55–1.02 | 0.070 |
Age (per every additional year of age) | 0.97 | 0.97–0.98 | < 0.001 | 0.99 | 0.98–0.99 | 0.011 |
Acute intracranial hemorrhage | 0.27 | 0.16–0.46 | < 0.001 | 0.28 | 0.16–0.48 | < 0.001 |
SE severity (as quantified by the STESS) | 0.36 | 0.27–0.49 | < 0.001 | 0.49 | 0.33–0.73 | < 0.001 |
SE type | 0.90 | 0.73–1.11 | 0.313 | 1.07 | 0.83–1.38 | 0.584 |
In-hospital death | ||||||
Female sex | 1.34 | 0.77–2.32 | 0.295 | 1.40 | 0.77–2.53 | 0.268 |
Age (per every additional year of age) | 1.04 | 1.02–1.06 | < 0.001 | 1.04 | 1.01–1.06 | 0.002 |
Acute intracranial hemorrhage | 2.13 | 1.08–4.20 | 0.030 | 1.87 | 0.89–3.90 | 0.097 |
SE severity (as quantified by the STESS) | 5.35 | 2.49–11.49 | < 0.001 | 1.64 | 0.64–4.23 | 0.304 |
SE type | 2.85 | 1.92–4.23 | < 0.001 | 2.77 | 1.78–4.32 | < 0.001 |
Death at 30 days follow-up | ||||||
Female sex | 1.34 | 0.77–2.32 | 0.295 | 1.27 | 0.90–1.80 | 0.177 |
Age (per every additional year of age) | 1.04 | 1.02–1.06 | < 0.001 | 1.04 | 1.03–1.05 | < 0.001 |
Acute intracranial hemorrhage | 2.13 | 1.08–4.20 | 0.030 | 1.19 | 0.72–1.97 | 0.492 |
SE severity (as quantified by the STESS) | 2.05 | 1.45–2.89 | < 0.001 | 0.96 | 0.60–1.52 | 0.849 |
SE type | 1.26 | 0.99–1.59 | 0.059 | 1.44 | 1.09–1.90 | 0.010 |
Secondary outcomes | ||||||
---|---|---|---|---|---|---|
Univariable model | Multivariable model* corrected for the influence of both centers |
|||||
Potential influences on treatment decisions (as identified in Table 1) |
OR | 95% CI | p value | OR | 95% CI | p value |
Use of anesthetics | ||||||
Female sex | 0.55 | 0.41–0.76 | < 0.001 | 0.64 | 0.45–0.91 | 0.013 |
Age (per every additional year of age) | 0.97 | 0.97–0.98 | < 0.001 | 0.98 | 0.97–0.99 | < 0.001 |
Acute intracranial hemorrhage | 1.50 | 0.96–2.34 | 0.073 | 1.32 | 0.78–2.21 | 0.299 |
SE type | 2.77 | 2.18–3.52 | < 0.001 | 3.35 | 2.57–4.37 | < 0.001 |
Use of mechanical ventilation | ||||||
Female sex | 0.61 | 0.45–0.82 | 0.001 | 0.72 | 0.52–1.00 | 0.050 |
Age (per every additional year of age) | 0.98 | 0.97–0.99 | < 0.001 | 0.98 | 0.97–0.99 | < 0.001 |
Acute intracranial hemorrhage | 2.39 | 1.54–3.70 | < 0.001 | 2.46 | 1.50–4.03 | < 0.001 |
SE type | 2.84 | 2.25–3.60 | < 0.001 | 3.11 | 2.42–3.99 | < 0.001 |
OR = odds ratio; CI = confidence interval; SE = status epilepticus; STESS = status epilepticus severity score
*All Hosmer–Lemeshow goodness-of-fit tests insignificant indicating adequate model fit
Bold font indicates statistical significance (with a p value set at ≤0.05)